Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
Conditions
Type 1 Diabetes · Diabetes Mellitus, Type 1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
Contact: Principal Investigator (Francesco Vendrame, MD)Rodolfo Alejandro, MD (Sub-investigator)
Study leads
Francesco Vendrame, MD
Principal Investigator
University of Miami, Diabetes Research Institute